| GTO ID | GTC0952 |
| Trial ID | ChiCTR2100052677 |
| Disease | B-Cell Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Single-Center, single-arm, non-blind safety and effectiveness clinical study of improved CAR-T cell therapy for B-cell lymphoma |
| Year | 2021 |
| Country | China |
| Company sponsor | Tianjin First Central Hospital |
| Cohort 1 | |||||||
|
|||||||